← All Alaunos Therapeutics, INC filings

Alaunos Therapeutics, INC Form 4 insider transactions

NASDAQ
TCRT
Alaunos Therapeutics, INC
Form 4: Alaunos Therapeutics Executive Acquires Stock Options
Melinda Lackey, Legal & Administration Officer at Alaunos Therapeutics, acquires stock options as per SEC Form 4 filing.
NASDAQ
TCRT
Alaunos Therapeutics, INC
Form 4: Alaunos Therapeutics VP Acquires Stock Options
Ferdinand Groenewald, VP of Finance at Alaunos Therapeutics, acquired stock options on March 29, 2025.
NASDAQ
TCRT
Alaunos Therapeutics, INC
Form 4: Alaunos Therapeutics Director Jaime Vieser Sells Shares
Director Jaime Vieser of Alaunos Therapeutics, Inc. (TCRT) sold a portion of their common stock holdings on December 31, 2024.
NASDAQ
TCRT
Alaunos Therapeutics, INC
Form 4: Alaunos Therapeutics VP of Finance Acquires Stock Options
Ferdinand Groenewald, VP of Finance at Alaunos Therapeutics, acquired stock options on August 14, 2024.
NASDAQ
TCRT
Alaunos Therapeutics, INC
Form 4: Alaunos Therapeutics Officer Acquires Stock Options
Melinda Lackey, Legal & Administration Officer at Alaunos Therapeutics, acquired stock options on August 14, 2024.
NASDAQ
TCRT
Alaunos Therapeutics, INC
Form 4: Alaunos Therapeutics Director Acquires Stock Options
Holger Weis, a director of Alaunos Therapeutics, acquired stock options on June 6, 2024, according to a Form 4 filing.
NASDAQ
TCRT
Alaunos Therapeutics, INC
Form 4: Alaunos Therapeutics Director Acquires Stock Options
Jaime Vieser, a director of Alaunos Therapeutics, acquired employee stock options on June 6, 2024.
NASDAQ
TCRT
Alaunos Therapeutics, INC
Form 4: Alaunos Therapeutics Director Acquires Stock Options
Robert W. Postma, a director of Alaunos Therapeutics, acquired 12,800 employee stock options on June 6, 2024.
NASDAQ
TCRT
Alaunos Therapeutics, INC
Form 4: Alaunos Therapeutics Director Acquires Stock Options
Robert Hofmeister, a director at Alaunos Therapeutics, acquired 12,800 employee stock options on June 6, 2024.